RICHARD A MD MILLER, the President and CEO of $CRVS, bought 1,932 shares of the company on 05-18-2026 for an estimated $23,203. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.2%. Following this trade, they now own 1,195,035 shares of this class of $CRVS stock.
$CRVS Insider Trading Activity
$CRVS insiders have traded $CRVS stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CRVS stock by insiders over the last 6 months:
- RICHARD A MD MILLER (President and CEO) has made 2 purchases buying 6,932 shares for an estimated $83,453 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CRVS Hedge Fund Activity
We have seen 115 institutional investors add shares of $CRVS stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,883,195 shares (+8453.9%) to their portfolio in Q1 2026, for an estimated $42,181,142
- POINT72 ASSET MANAGEMENT, L.P. removed 2,875,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $42,061,250
- DEEP TRACK CAPITAL, LP added 2,491,539 shares (+inf%) to their portfolio in Q1 2026, for an estimated $36,451,215
- COMMODORE CAPITAL LP added 2,258,735 shares (+inf%) to their portfolio in Q1 2026, for an estimated $33,045,293
- WELLINGTON MANAGEMENT GROUP LLP added 2,003,834 shares (+636.8%) to their portfolio in Q1 2026, for an estimated $29,316,091
- PERCEPTIVE ADVISORS LLC added 1,600,000 shares (+231.1%) to their portfolio in Q1 2026, for an estimated $23,408,000
- HOOD RIVER CAPITAL MANAGEMENT LLC added 1,335,109 shares (+inf%) to their portfolio in Q1 2026, for an estimated $19,532,644
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CRVS Analyst Ratings
Wall Street analysts have issued reports on $CRVS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/22/2026
- Oppenheimer issued a "Outperform" rating on 01/21/2026
- HC Wainwright & Co. issued a "Buy" rating on 01/20/2026
To track analyst ratings and price targets for $CRVS, check out Quiver Quantitative's $CRVS forecast page.
$CRVS Price Targets
Multiple analysts have issued price targets for $CRVS recently. We have seen 5 analysts offer price targets for $CRVS in the last 6 months, with a median target of $33.0.
Here are some recent targets:
- Paul Choi from Goldman Sachs set a target price of $40.0 on 04/17/2026
- Jeff Jones from Oppenheimer set a target price of $33.0 on 03/13/2026
- Roger Song from Jefferies set a target price of $42.0 on 01/22/2026
- Etzer Darout from Barclays set a target price of $28.0 on 01/21/2026
- Sean Lee from HC Wainwright & Co. set a target price of $27.0 on 01/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
